Clinical Trial Update: Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults [Phase 3]

View source ↗

Summary

A completed Phase 3 clinical trial for attention-deficit/hyperactivity disorder in adults sponsored by GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Snippet

Sponsor: GlaxoSmithKline | Conditions: Attention Deficit Disorder | Phase 3 | Status: COMPLETED